Skip to content

CNO Financial Group CNO Funding agreements — Deferred Policy Acquisition Cost, Capitalization

Other product segments

Traditional life
$26.9M-12.4%
Fixed indexed annuities
$25.4M+3.3%
Supplemental health
$17.7M-1.1%
Medicare supplement
$10.3M+43.1%
Interest-sensitive life
$9.4M+10.6%
Long-term care
$8.3M+20.3%
Fixed interest annuities
$2.3M-34.3%

Other financials

Income statement

See full
Revenue$1.0B+2.5%
Net income$37.7M+75.3%
EPS (diluted)$0.39+85.7%

Balance sheet

See full
Cash & equivalents$1.2B+12.6%
Total debt$1.4B-41.0%
Total equity$2.5B-2.2%
Total assets$39.0B+4.1%

Cash flow

See full
Operating cash flow$148.8M+8.9%

Valuation

See full
Market cap$4.93B-7.9%

Profitability

See full
Net margin5.4%-2.2pp

Returns & leverage

See full
Return on equity9.7%-3.7pp
Debt / equity0.5×-0.4×

Where this comes from

Reported directly by CNO Financial Group in its filing.

Tagged under the XBRL concept us-gaap:DeferredPolicyAcquisitionCostsAdditions.

The official record: CNO Financial Group’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CNO Financial Group's funding agreements — deferred policy acquisition cost, capitalization.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CNO Financial Group's funding agreements — deferred policy acquisition cost, capitalization?
CNO Financial Group (CNO) reported funding agreements — deferred policy acquisition cost, capitalization of $300K in Q1 2026.
What is the long-term trend for CNO Financial Group's funding agreements — deferred policy acquisition cost, capitalization?
Over 3 years (2021 to 2025), CNO Financial Group's funding agreements — deferred policy acquisition cost, capitalization has grown at a 2.9% compound annual growth rate (CAGR), from $3.4M to $3.7M.
What does funding agreements — deferred policy acquisition cost, capitalization mean?
This metric measures the total incremental costs incurred and capitalized during a period to acquire new funding agreement contracts. It captures the initial investment required to originate these liabilities, which are subsequently amortized over the life of the agreements. Tracking this helps investors understand the company's current sales velocity and the associated upfront investment intensity for the funding agreement segment.